Choose the experimental features you want to try

This document is an excerpt from the EUR-Lex website

Document 62019TA0817

Case T-817/19: Judgment of the General Court of 27 January 2021 — Olimp Laboratories v EUIPO — OmniVision (Hydrovision) (EU trade mark — Opposition proceedings — Application for EU figurative mark Hydrovision — Earlier EU word mark Hylo-Vision — Relative ground for refusal — Likelihood of confusion — Article 8(1)(b) of Regulation (EC) No 207/2009 (now Article 8(1)(b) of Regulation (EU) 2017/1001))

OJ C 88, 15.3.2021, pp. 28–28 (BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

15.3.2021   

EN

Official Journal of the European Union

C 88/28


Judgment of the General Court of 27 January 2021 — Olimp Laboratories v EUIPO — OmniVision (Hydrovision)

(Case T-817/19) (1)

(EU trade mark - Opposition proceedings - Application for EU figurative mark Hydrovision - Earlier EU word mark Hylo-Vision - Relative ground for refusal - Likelihood of confusion - Article 8(1)(b) of Regulation (EC) No 207/2009 (now Article 8(1)(b) of Regulation (EU) 2017/1001))

(2021/C 88/36)

Language of the case: English

Parties

Applicant: Olimp Laboratories sp. z o.o. (Dębica, Poland) (represented by: M. Kondrat, lawyer)

Defendant: European Union Intellectual Property Office (represented by: D. Walicka, acting as Agent)

Other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court: OmniVision GmbH (Puchheim, Germany) (represented by: B. Sorg, D. Wiedemann and M. Ringer, lawyers)

Re:

Action brought against the decision of the Second Board of Appeal of EUIPO of 13 September 2019 (Case R 2371/2018 2), relating to opposition proceedings between OmniVision and Olimp Laboratories.

Operative part of the judgment

The Court:

1.

Dismisses the action;

2.

Orders Olimp Laboratories sp z o.o. to pay the costs.


(1)  OJ C 27, 27.1.2020.


Top